(CercleFinance.com) – Aton (Hybrigenics) announced on Friday evening that it had postponed its target of a turnover of 60 million euros by 2025 ‘to a later financial year’, which caused its stock to fall on the stock market. from Paris.
The medical science specialist explains that he considered it reasonable to shift his financial objectives in view of current economic conditions and the difficulties in raising funds.
Although it says it has initiated several discussions with investment funds, the group explains that the completion of these operations remains uncertain, which immediately rules out the scenario of an acceleration in the development of its subsidiaries.
As for 2024, Aton says it is aiming for growth in its activity, but less sustained than the expected level, and which should not allow operational balance to be achieved.
Following all these announcements, the stock fell by more than 27% on Monday on the Paris Stock Exchange.
Copyright © 2023 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends using the buttons below.
